# Weiyi Ni

Weiyi Ni is a remote worker on Himalayas, Head of RWE Analytics at Jazz Pharmaceuticals, based in United States.

Source: https://himalayas.app/@weiyini

```text
Head of RWE analytics driving evidence generation for market access, pricing, and reimbursement through real-world data and HEOR.
```

| Detail | Value |
| --- | --- |
| Availability | Open to opportunities |
| Location | United States |
| Authorized to work in | United States |
| Job categories | RWE Strategy Lead, Health Economist, Health Outcomes Research, Real World Evidence Analyst, Data Science, Head Of Analytics, Head Of Data And Analytics, Director Of Analytics |
| Skills | Integrated Evidence Planning, Real World Evidence (RWE), Observational Studies, Epidemiological Research, Data Curation, Data Quality, Metadata Management, Data Lineage, Scalable Infrastructure, Regulatory Compliance, Healthcare Resource Utilization, Cost Effectiveness Analysis, Budget Impact Analyses, Economic Modeling, Value Proposition Development, literature review, Data Visualization, Data Governance, SOP Development, Cross functional Leadership, SAS, Stata, SPSS, R, SQL, BigQuery, Machine Learning Algorithms, Risk, Arena, EMR Data Analysis, Claims Data Analysis, Orleans, Jackson, Gordon, Novel, Synthesized, Black, Burn, Tremor, Jazz, Movement |

## What I'm looking for

```text
I’m looking to lead integrated RWE/HEOR programs that generate decision-ready evidence for market access and reimbursement, with strong scientific rigor, compliant SOPs, and cross-functional partnership—backed by modern data governance and scalable analytics.
```

## About

```text
I lead integrated evidence generation strategy to close clinical and global market access–related evidence gaps in partnership with medical affairs, commercial, regulatory, and clinical development teams. I’m especially focused on observational and epidemiologic study design that produces decision-ready real-world evidence.

In my most recent roles as Head of RWE Analytics and Director, Global Value – HEOR at Jazz Pharmaceuticals, I oversaw pivotal RWE studies to support launches, including work for Xywav and Ziihera in the U.S. market. I also directed HCRU studies using Optum Market Clarity to inform post-approval strategy and payer engagement in biliary tract cancer.

I build rigorous evidence programs end-to-end—planning, data curation, and analysis—using EMR, claims, registry, genomic, and survey data to generate evidence on disease burden, treatment patterns, effectiveness, and safety. I’ve also developed enterprise-wide reimbursement strategies and strengthened real-world data governance through implementation of data quality standards, metadata governance, data lineage, and scalable infrastructure for reproducibility, traceability, and regulatory readiness.

I enjoy communicating complex findings clearly to clinical, regulatory, and policy stakeholders, supported by a strong publication record and scientific presentations. I’ve led and mentored high-performing RWE teams, established global RWE operating frameworks and SOPs, and championed advanced data visualization to improve how RWE results—like comorbidity and HCRU profiles—translate into actionable payer-facing value propositions.
```

## Experience

### Head of RWE Analytics

[Jazz Pharmaceuticals](https://himalayas.app/companies/jazz-pharmaceuticals). Dec 2022 - Apr 2026

```text
Led RWE analytics and integrated evidence generation efforts to support global market access, pricing, and reimbursement. Managed cross-functional evidence programs, real-world data governance, and SOP/framework development to ensure scientific rigor and regulatory readiness.
```

Skills: Real-World-Evidence-(RWE), Integrated-Evidence-Generation, Health-Economics-and-Outcomes-Research-(HEOR), Data-Governance, Data-Lineage, Reimbursement-Strategy, Data-Visualization, Cross-functional-Leadership, Optum-Market-Clarity, SAS, Stata, SPSS, R, Panalgo-Instant-Health-Data

### Director, Global Value – HEOR

[Jazz Pharmaceuticals](https://himalayas.app/companies/jazz-pharmaceuticals). Oct 2020 - Nov 2022

```text
Directed global HEOR and value evidence programs by planning and executing real-world studies to close evidence gaps for market access and reimbursement. Translated analytical findings into stakeholder-facing value propositions for medical, regulatory, and commercial teams.
```

Skills: HEOR, Real-World-Evidence-(RWE), Healthcare-Data, Economic-Modeling, literature-review, Value-Proposition-Development, Payer-Engagement, Reimbursement-Strategy, Data-Visualization, Cross-Functional-Collaboration, SAS, Stata, SPSS, R, Panalgo-Instant-Health-Data

### Senior Health Economist

[Medtronic](https://himalayas.app/companies/medtronic). Jul 2018 - Oct 2020

```text
Conducted cost-effectiveness and administrative claims analyses to support market access and reimbursement strategy. Produced payer-facing value briefs and synthesized evidence across literature, clinical trials, and claims to inform value-based healthcare strategy.
```

Skills: Cost-Effectiveness-Analysis, Value-Briefs, Cross-Functional-Collaboration, SAS, Stata, SPSS, R

### Associate Director, Health Outcomes Res.

Millennium Health. Sep 2017 - Jan 2018

```text
Led health outcomes research activities using EMR data and developed economic models to evaluate clinical and economic impact. Supported payer-perspective budget impact analyses for diagnostic and policy-related strategies.
```

Skills: Health-Outcomes-Research, EMR-Based-Retrospective-Study, Budget-Impact-Analyses, Health-Economics-and-Outcomes-Research-(HEOR), Cross-Functional-Collaboration, SAS, Stata, SPSS, R

### Senior Manager, Health Outcomes Research

Millennium Health. Sep 2016 - Sep 2017

```text
Conducted health outcomes research using EMR data to assess healthcare utilization and costs associated with clinical outcomes. Built budget impact models to evaluate the economic value of diagnostics in inpatient settings and supported managed markets analyses for payer impact.
```

Skills: Health-Outcomes-Research, EMR-Based-Retrospective-Study, Budget-Impact-Analyses, Healthcare-Utilization-Management, Claims-Analysis, SAS, Stata, SPSS, R

### Consultant

EconoMedRx. May 2014 - Sep 2016

```text
Performed cost-effectiveness analyses and developed analytic methods to support reimbursement and access decisions. Supported claims-based investigations including lines-of-therapy algorithms and identification of off-label medication use.
```

Skills: Cost-Effectiveness-Analysis, Diagnostic-Test-Economic-Evaluation, Empirical-Payment-Modeling, Off-Label-Utilization-Identification, Drug-Indication, SAS, Stata, SPSS, R

## Education

### University of Southern California

Doctor of Philosophy, Pharmaceutical Economics and Policy. 2012 - 2017

```text
Ph.D. in Pharmaceutical Economics and Policy from the University of Southern California (2012–2017).
```

### University of Florida

Doctor of Philosophy, Medical Sciences (Genetics). 2007 - 2012

```text
Ph.D. in Medical Sciences – Genetics with a minor in Statistics from the University of Florida (2007–2012). Dissertation: “Investigation of the Status of Recombinant Adeno-Associated Viral Vectors in Non-Human Primate Peripheral Blood Mononuclear Cells Transduced Collaterally in vivo.”
```

### Fudan University

Bachelor of Science, Biological Sciences. 2003 - 2007

```text
B.S. in Biological Sciences from Fudan University (2003–2007).
```

### University of Southern California

Master of Arts, Economics

```text
M.A. in Economics from the University of Southern California. Dissertation: “Impact of Pharmacy-Based Transitional Care on Healthcare Utilization and Costs.”
```

## Tech stack

- SAS
- Orleans
- Jackson
- F#
- Gordon
- Google BigQuery
- SQL
- Stata
- Synthesized
- Black
- Burn
- Tremor
- Novel
- Jazz
- Movement
- X++

To contact Weiyi, message them from this profile with a Himalayas employer account: [Hire on Himalayas](https://himalayas.app/hire).

## People also viewed

- [Grant Scheiffele](https://himalayas.app/@grantscheiffele): Data Analyst, University of Florida College of Pharmacy
- [Lauren Marino](https://himalayas.app/@laurenmarino): Development Associate, Edmarc Hospice for Children
- [Oluwakayode Adejoro](https://himalayas.app/@oluwakayodeadejoro): Director, Global Market Access, Johnson & Johnson Innovative Medicines
- [Melissa DeSanto](https://himalayas.app/@melissadesanto): Lead Bio Statistician, Meditrial
- [Dana Franklin](https://himalayas.app/@danxfrank): Data Infrastructure Manager, South Side Healthy Community Organization
- [Patrick Leon](https://himalayas.app/@patrickleon): Senior Healthcare Analyst, Health Services Advisory Group (HSAG)
- [Brian Cronin](https://himalayas.app/@briancronin): Clinical Business Intelligence Manager, Mass General Brigham Health Plan
- [Kenneth Huang](https://himalayas.app/@kennethhuang): Medical Informatics Consultant, KENEFLY Healthcare Analytics LLC
- [Brandi Caughorn](https://himalayas.app/@brandicaughorn): Healthcare Economics Analyst I, Capital Health Plan
- [Kandis Martin](https://himalayas.app/@kandismartin): Consultant, HEOR/RWE/ Clinical Research, Independent
